Statins and the risk of dementia
The LancetPublished 1 November 2000
Hershel Jick, GL Zornberg, Susan S. Jick, Sudha Seshadri, DA Drachman
Citations1,767
SJR quartileQ1
SJR score12.11
SNIP22.72
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Individuals of 50 years and older who were prescribed statins had a substantially lowered risk of developing dementia, independent of the presence or absence of untreated hyperlipidaemia, or exposure to nonstatin LLAs.
Abstract
Individuals of 50 years and older who were prescribed statins had a substantially lowered risk of developing dementia, independent of the presence or absence of untreated hyperlipidaemia, or exposure to nonstatin LLAs. The available data do not distinguish between Alzheimer's disease and other forms of dementia.
Keywords
Medicine
NeurologyClinical diagnosis of Alzheimer's disease
27,993 Citations1984Guy M. McKhann, David A. Drachman +4 more
The criteria proposed are intended to serve as a guide for the diagnosis of probable, possible, and definite Alzheimer's disease; these criteria will be revised as more definitive information becomes available.
Evidence-Based Medicine: How to Practice and Teach EBM
5,970 Citations2000David L. Sackett
This chapter discusses how to ask clinical questions you can answer and critically assess the evidence for evidence-based medicine, as well as 7 Rapid Reference Cards used in clinical practice.
NeurologyVascular dementia
4,855 Citations1993Gustavo C. Román, T. K. Tatemichi +29 more
These criteria for the diagnosis of vascular dementia are intended as a guide for case definition in neuroepidemiologic studies, stratified by levels of certainty (definite, probable, and possible).
NeurologyConsensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB)
3,952 Citations1996Ian G. McKeith, Douglas Galasko +23 more
This work identified progressive disabling mental impairment progressing to dementia as the central feature of DLB, and identified optimal staining methods for each of these and devised a protocol for the evaluation of cortical LB frequency based on a brain sampling procedure consistent with CERAD.
NeurologyAssociation of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
3,780 Citations1993Ann M. Saunders, Warren J. Strittmatter +12 more
Data support the involvement of ApoE epsilon 4 in the pathogenesis of late-onset familial and sporadic AD and suggest it may operate as a susceptibility gene (risk factor) for the clinical expression of AD.
JAMABrain Infarction and the Clinical Expression of Alzheimer Disease<subtitle>The Nun Study</subtitle>
1,579 Citations1997David A. Snowdon
Findings suggest that cerebrovascular disease may play an important role in determining the presence and severity of the clinical symptoms of AD.
Archives of NeurologyDecreased Prevalence of Alzheimer Disease Associated With 3-Hydroxy-3-Methyglutaryl Coenzyme A Reductase Inhibitors
1,405 Citations2000Benjamin Wolozin
There is a lower prevalence of diagnosed probable AD in patients taking 2 different 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors-lovastatin and pravastatin, which warrants further study.
The LancetAtherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study
1,374 Citations1997Albert Hofman, Alewijn Ott +7 more
It is suggested that dementia and its two major subtypes Alzheimer's disease and vascular dementia are associated with atherosclerosis and that there is an interaction between apolipoprotein E and Atherosclerosis in the aetiology of Alzheimer’s disease.
JAMAEvidence-based Medicine: How to Practice and Teach EBM
977 Citations1997Saty Satya‐Murti
Evidence-based Healthcare: How to Make Health Policy and Management Decisions, by J. A. Muir Gray is a guide to applying valid evidence and data to a specific clinical question engendered during patient care.
New England Journal of MedicineDrug Treatment of Lipid Disorders
847 Citations1999Robert H. Knopp
Arteriosclerosis of the coronary and peripheral vasculature is the leading cause of death among men and women in the United States and worldwide and nationwide; nationwide, the mortality rate for cardiovascular disease is approximately 50 percent.
JAMABrain Infarction and the Clinical Expression of Alzheimer Disease-Reply
684 Citations1997David A. Snowdon
Among the participants in this study who met the neuropathologic criteria for AD, those with 1 or 2 lacunar infarcts in the basal ganglia, thalamus, or deep white matter had an especially high prevalence of dementia, compared with those without brain infarCTs.
NeuroepidemiologySerum Total Cholesterol, Apolipoprotein E {FC12}e4 Allele, and Alzheimer’s Disease
676 Citations1998Irma-Leena Notkola, Raimo Sulkava +6 more
It is concluded that high serum total cholesterol may be an independent risk factor for AD and some of the effect of the apoE epsilon 4 allele on risk of AD might be mediated through high serum cholesterol.
JAMAMultivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects
629 Citations1989Aubrey Milunsky
British Journal of Clinical PharmacologyUse of the UK General Practice Research Database for pharmacoepidemiology
559 Citations1998Luis A. Garcı́a Rodrı́guez, Susana Perez‐Gutthann
The General Practice Research Database in the UK has proved that valuable data can be collected in a general practice setting and should serve to encourage others to develop similar population-based data in other countries.
JAMAMultivitamin/Folic Acid Supplementation in Early Pregnancy Reduces the Prevalence of Neural Tube Defects
485 Citations1989Aubrey Milunsky
The relation of multivitamin intake in general, and folic acid in particular, to the risk of neural tube defects in a cohort of 23,491 women undergoing maternal serum alpha-fetoprotein screening or amniocentesis around 16 weeks of gestation was examined.
NeurologyInteractions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease
373 Citations1995G.P. Jarvik, Ellen M. Wijsman +4 more
A pathologic role of higher TC or cholesterol-based differential survival of ϵ4-carrying individuals may be involved in the relationship of the ϵ 4 allele with AD.
Journal of the American College of CardiologyPravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions
340 Citations1999Wayne Kaesemeyer, Ruth B. Caldwell +2 more
Clinical benefits with PRA not explained by LDL reductions may be the result of an independent action of PRA on eNOS activation, but SIM is much less effective.
NeuroreportThe role of cholesterol in the biosynthesis of β-amyloid.
324 Citations1999Emma R. Frears, David Stephens +3 more
Changes in APP processing by cholesterol may mediate the way in which the ApoE4 allele increases risk of developing Alzheimer's disease (AD) in western populations.
American Journal of EpidemiologyPostmenopausal Estrogen Replacement Therapy and the Risk of Alzheimer's Disease: A Population-based Case-Control Study
303 Citations1994Daniel E. Brenner, Walter A. Kukull +6 more
This study provides no evidence that estrogen replacement therapy has an impact on the risk of Alzheimer's disease in women.
Pharmacoepidemiology and Drug SafetyFurther validation of information recorded on a general practitioner based computerized data resource in the united kingdom
266 Citations1992Hershel Jick, Barbara Z. Terris +2 more
Evaluating the quality and completeness of the data recorded by GPs on VAMP computers for the purpose of carrying out drug safety studies found that clinical diagnoses reflecting the diagnoses noted in the consultant letters were present on the computer 87% of the time.
Current Opinion in LipidologyLow-density lipoprotein-independent effects of statins
246 Citations1999Jean Davignon, Reijo Laaksonen
Pleiotropic effects are currently being given consideration when instituting combination therapy for patients at high cardiovascular risk and the challenge for the future will be to design and carry out appropriate clinical trials to establish their relative importance in the prevention of coronary artery disease.
Archives of NeurologyInheritance of Frontotemporal Dementia
205 Citations1999Tiffany W. Chow, Bruce L. Miller +2 more
Familial FTD is usually inherited in an autosomal dominant pattern, and the initial onset is insidious, often consisting of mood and behavioral changes occurring in presenile years that are often erroneously attributed to other nonneurologic causes.
Annals of the New York Academy of SciencesBrain Microvascular Changes in Alzheimer's Disease and Other Dementias<sup>a</sup>
167 Citations1997Luc Buée, Patrick R. Hof +1 more
If vasculopathy in neurodegenerative disorders is not directly involved in pathogenesis, it may act synergistically with other pathogenetic mechanisms including genetic and environmental factors.
Archives of NeurologyPostmenopausal Estrogen Replacement Therapy and the Risk of Alzheimer Disease
147 Citations2001Sudha Seshadri, Gwen L. Zornberg +4 more
The use of ERT in women after the onset of menopause was not associated with a reduced risk of developing Alzheimer disease, and the odds ratios were similar for estrogen recipients who received estrogens alone and recipient who received combined estrogen-progestin treatment.
The British Journal of PsychiatryIncidence of Clinically Diagnosed Subtypes of Dementia in an Elderly Population
146 Citations1995Carol Brayne, C. Gill +6 more
The striking rise in incidence rates of dementia in the very old appear to be due to Alzheimer's disease, while rates for vascular dementia remain relatively constant, but trends are particularly marked for minimal dementia, but emphasise the importance of Alzheimer's Disease in the community as a cause of cognitive decline of all degrees.
BMJRegular Aspirin Intake and Acute Myocardial Infarction
141 Citations1974
The results of two large independent studies showed a negative association between regular aspirin intake and non-fatal myocardial infarction, consistent with the hypothesis that aspirin protects against this disease.
NeurologyHMG-CoA reductase inhibitors (statins)
115 Citations2000David C. Hess, Andrew M. Demchuk +2 more
The best current evidence for stroke prevention is with pravastatin and simvastatin, and future studies of statins are needed in stroke populations, particularly the elderly.
Brain and CognitionFronto-temporal Dementia: Nosology, Neuropsychology, and Neuropathology
114 Citations1996David Neary, Julie S. Snowden
Phenotypic characterization of patients at each level of description: clinical, anatomical, and histological, provides a foundation for the molecular genetic studies which ought to shed light on the etiology of this form of focal cerebral degeneration.
Archives of NeurologyRole of the Low-density Lipoprotein Receptor–Related Protein in β-Amyloid Metabolism and Alzheimer Disease
102 Citations2000Bradley T. Hyman, Dudley K. Strickland +1 more
Data is highlighted that support a role for LRP in A beta metabolism and hypothesize that LRP therefore plays a critical role in Alzheimer disease.
Annals of NeurologyAssociation between Alzheimer's disease and theNOS3 gene
98 Citations1999Mohammed Dahiyat, Alastair M. Cumming +7 more
A highly significant enrichment for Glu/Glu homozygotes in LOAD compared with controls appears to be independent of ApoE status, and NOS3 may be a new genetic risk factor for LOAD.
Annals of the New York Academy of SciencesClinical Studies of Cerebral Blood Flow in Alzheimer's Disease
96 Citations1997William J. Jagust, Jamie L. Eberling +3 more
In multiple brain regions, including the temporal lobes, AD patients showed robust and significant increases in perfusion in response to carbon dioxide that did not differ from the response seen in the controls.
Annals of the New York Academy of SciencesCerebrovascular Pathology in Alzheimer's Disease: Cause, Effect or Epiphenomenon?
90 Citations1997Vladimir Hachinski, David G. Muñoz
This volume addresses some of the issues surrounding changes in the endothelium, disruption of the blood‐brain barrier and amyloid deposition in the cerebral blood vessels in Alzheimer's disease by presenting new knowledge gained from a diversity of fields.
The LancetPrinciples of epidemiological research on adverse and beneficial drug effects
77 Citations1998Hershel Jick, Luis A. Garcı́a Rodrı́guez +1 more
The important general principles of drug epidemiological research that should be used to assess the quality and validity of studies are described.
Neurobiology of AgingAberrant expression of nitric oxide synthase III in Alzheimer’s disease: relevance to cerebral vasculopathy and neurodegeneration
58 Citations2000Suzanne M. de la Monte, B-X Lu +5 more
The aggregate findings suggest that cell loss and neurodegeneration may be mediated by somewhat distinct but overlapping mechanisms in AD and AD+CVD.
The Journal of the American Medical Association (JAMA) Network (American Medical Association)Textbook of Neurology
46 Citations1998Marc Fisher, Julien Bogousslavsky
The Neurologic Examination Clinical and Biochemical Neuroanatomy Neuroimaging Clinical Neurophysiology Neurosonology Neuroimmunology Molecular Biology and Genetics in Neurological Disorders Neuropharmacology Neuro-Ophthalmology Neuroepidemiology Cerebrospinal Fluid, Cerebro Spine Dynamics, and Lumbar Puncture Behavioral Neurology are studied.
BMJDiseases causing end-stage renal failure in New South Wales.
42 Citations1975John H. Stewart, S W McCarthy +4 more
Greater use of micturating cystography and cystoscopy and routine urine testing for salicylate are advocated for earlier diagnosis of the major causes of "pyelonephritis".
Australian & New Zealand Journal of PsychiatryBook Review: Neurobiology of Primary Dementia
8 Citations1999Colin L. Masters